This clinical quality registry aims to improve myeloma outcomes by providing an evidence base for the best strategies to diagnose, treat and support people with myeloma and related diseases.
Patients with multiple myeloma
Number of approved sites
Join us for the Myeloma and Related Diseases Registry (MRDR) Interest Group breakfast at Blood 2022.Read more
Paper on on early mortality in multiple myeloma accepted for publication!Read more
Thanks to those who contribute to improving care, and providing support for people living with myeloma & related diseases!Read more